{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:34:07Z","timestamp":1787243647443,"version":"build-2736575974"},"reference-count":114,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of this Review<\/jats:title>\n                    <jats:p>Rare diseases, although individually infrequent, collectively impact a substantial number of people. Collaborative translational research using biospecimens is essential for advancing our understanding of the diverse characteristics and pathophysiology of rare diseases. Biobanks play a pivotal role in this endeavor by collecting, processing, transporting, and storing biospecimens, thereby serving as invaluable resources for medical research. In this review, we explore currently available biobanks, with a specific focus on those dedicated to rare rheumatic diseases. We also examine accessible best practice guidelines for establishing and maintaining high-quality biobanks, discuss the limitations and propose future directions for enhancing biobanking efforts in rare disease research.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>Advances in molecular and genomic technologies have expanded the role of biobanks, enhancing biomarker discovery and precision medicine. However, despite growth in biobanking capabilities, key challenges persist concerning ethics, interoperability, and biospecimen exchange, prompting active responses by various regulatory and governing bodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Biobanking has transformed rare disease research. Strengthening national and international collaborations is essential for driving progress in this field and accelerating the development of novel therapeutic and precision medicine approaches.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11926-025-01189-6","type":"journal-article","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:33:45Z","timestamp":1747787625000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Biorepositories For Global Rare Disease Research: A Narrative Review"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1921-7370","authenticated-orcid":false,"given":"Maria Rosa","family":"Pellico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8528-4361","authenticated-orcid":false,"given":"Jessica","family":"Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3308-7231","authenticated-orcid":false,"given":"Meera","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2385-2591","authenticated-orcid":false,"given":"Belina Y.","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1878-8591","authenticated-orcid":false,"given":"Lesley Ann","family":"Saketkoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6171-1952","authenticated-orcid":false,"given":"Christian","family":"Lood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2753-2990","authenticated-orcid":false,"given":"Latika","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"issue":"2","key":"1189_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S2213-8587(19)30006-3","volume":"7","author":"The Lancet Diabetes Endocrinology null","year":"2019","unstructured":"The Lancet Diabetes Endocrinology null. Spotlight on rare diseases. Lancet Diabetes Endocrinol. 2019;7(2):75.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"1189_CR2","doi-asserted-by":"publisher","first-page":"e229","DOI":"10.1016\/S2665-9913(22)00072-8","volume":"4","author":"TL Rheumatology","year":"2022","unstructured":"Rheumatology TL. Long-awaited action on rare diseases. The Lancet Rheumatology. 2022;4(4):e229.","journal-title":"The Lancet Rheumatology"},{"issue":"2","key":"1189_CR3","doi-asserted-by":"publisher","first-page":"49","DOI":"10.2147\/BSAM.S46707","volume":"21","author":"CE Graham","year":"2014","unstructured":"Graham CE, Molster C, Baynam GS, Bushby K, Hansson M, Kole A, et al. Current trends in biobanking for rare diseases: a review. Journal of Biorepository Science for Applied Medicine. 2014;21(2):49\u201361.","journal-title":"Journal of Biorepository Science for Applied Medicine"},{"issue":"11","key":"1189_CR4","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1007\/s00296-011-1999-3","volume":"31","author":"AY Gasparyan","year":"2011","unstructured":"Gasparyan AY, Ayvazyan L, Blackmore H, Kitas GD. Writing a narrative biomedical review: considerations for authors, peer reviewers, and editors. Rheumatol Int. 2011;31(11):1409\u201317.","journal-title":"Rheumatol Int"},{"issue":"17","key":"1189_CR5","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12967-019-1922-3","volume":"22","author":"L Coppola","year":"2019","unstructured":"Coppola L, Cianflone A, Grimaldi AM, Incoronato M, Bevilacqua P, Messina F, et al. Biobanking in health care: evolution and future directions. J Transl Med. 2019;22(17):172.","journal-title":"J Transl Med"},{"issue":"4","key":"1189_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/s41416-022-02053-5","volume":"128","author":"MC Conroy","year":"2023","unstructured":"Conroy MC, Lacey B, Be\u0161evi\u0107 J, Omiyale W, Feng Q, Effingham M, et al. UK Biobank: a globally important resource for cancer research. Br J Cancer. 2023;128(4):519\u201327.","journal-title":"Br J Cancer"},{"issue":"1","key":"1189_CR7","first-page":"45","volume":"233","author":"G Berglund","year":"1993","unstructured":"Berglund G, Elmst\u00e4hl S, Janzon L, Larsson SA. The Malmo Diet and Cancer Study. Design and feasibility J Intern Med. 1993;233(1):45\u201351.","journal-title":"Design and feasibility J Intern Med"},{"issue":"1","key":"1189_CR8","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1186\/s12889-022-14163-z","volume":"22","author":"JY Hee","year":"2022","unstructured":"Hee JY, Huang S, Leong KP, Chun L, Zhang YO, Gongye R, et al. Pregnancy loss and the risk of rheumatoid arthritis in Chinese women: findings from the China Kadoorie biobank. BMC Public Health. 2022;22(1):1768.","journal-title":"BMC Public Health"},{"key":"1189_CR9","unstructured":"Biobank\u202f:SLICC [Internet]. [cited 2025 Feb 16]. Available from: https:\/\/sliccgroup.org\/research\/biobank\/"},{"issue":"4","key":"1189_CR10","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1159\/000292651","volume":"77","author":"D Shickle","year":"2010","unstructured":"Shickle D, Griffin M, El-Arifi K. Inter- and intra-biobank networks: classification of biobanks. Pathobiology. 2010;77(4):181\u201390.","journal-title":"Pathobiology"},{"issue":"3","key":"1189_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1089\/bio.2014.1231","volume":"12","author":"PH Watson","year":"2014","unstructured":"Watson PH. Biobank classification: communicating biorepository diversity. Biopreserv Biobank. 2014;12(3):163\u20134.","journal-title":"Biopreserv Biobank"},{"issue":"Suppl 2","key":"1189_CR12","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1136\/annrheumdis-2016-eular.2666","volume":"75","author":"T Kringelbach","year":"2016","unstructured":"Kringelbach T, Glintborg B, Johansen J, H\u00f8gdall E, Hetland ML. AB1053 The Nationwide Danish Rheumatologic Biobank \u2013 Paving The Road To Personalized Treatment of Patients with Inflammatory Rheumatic Diseases. Ann Rheum Dis. 2016;75(Suppl 2):1262\u20131262.","journal-title":"Ann Rheum Dis"},{"issue":"19\u201320","key":"1189_CR13","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1016\/j.cca.2012.04.030","volume":"413","author":"J Vaught","year":"2012","unstructured":"Vaught J, Lockhart N. The Evolution of Biobanking Best Practices. Clin Chim Acta. 2012;413(19\u201320):1569\u201375.","journal-title":"Clin Chim Acta"},{"issue":"5","key":"1189_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1089\/bio.2014.0099","volume":"13","author":"PR Quinlan","year":"2015","unstructured":"Quinlan PR, Groves M, Jordan LB, Stobart H, Purdie CA, Thompson AM. The Informatics Challenges Facing Biobanks: A Perspective from a United Kingdom Biobanking Network. Biopreserv Biobank. 2015;13(5):363\u201370.","journal-title":"Biopreserv Biobank"},{"issue":"2","key":"1189_CR15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/bio.2012.1022","volume":"10","author":"best practices for repositories collection","year":"2012","unstructured":"best practices for repositories collection. storage, retrieval, and distribution of biological materials for research international society for biological and environmental repositories. Biopreserv Biobank. 2012;10(2):79\u2013161.","journal-title":"Biopreserv Biobank"},{"issue":"8","key":"1189_CR16","doi-asserted-by":"publisher","first-page":"e13282","DOI":"10.1111\/cpr.13282","volume":"55","author":"G Dagher","year":"2022","unstructured":"Dagher G. Quality matters: International standards for biobanking. Cell Prolif. 2022;55(8):e13282.","journal-title":"Cell Prolif"},{"key":"1189_CR17","doi-asserted-by":"publisher","first-page":"5947","DOI":"10.1158\/1538-7445.AM2017-5947","volume":"77","author":"A Rao","year":"2017","unstructured":"Rao A, Vaught J, Guan P, Weil C, Moore H. Abstract 5947: The NCI Best Practices for Biospecimen Resources\u202f: 2016 revised recommendations. Can Res. 2017;77:5947\u20135947.","journal-title":"Can Res"},{"issue":"3","key":"1189_CR18","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.molonc.2008.07.004","volume":"2","author":"PHJ Riegman","year":"2008","unstructured":"Riegman PHJ, Morente MM, Betsou F, de Blasio P, Geary P. Biobanking for better healthcare. Mol Oncol. 2008;2(3):213\u201322.","journal-title":"Mol Oncol"},{"issue":"6","key":"1189_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1089\/bio.2023.0140","volume":"21","author":"E Snapes","year":"2023","unstructured":"Snapes E, Astrin JJ, Bertheussen Kr\u00fcger N, Grossman GH, Hendrickson E, Miller N, et al. Updating International Society for Biological and Environmental Repositories Best Practices, Fifth Edition: A New Process for Relevance in an Evolving Landscape. Biopreserv Biobank. 2023;21(6):537\u201346.","journal-title":"Biopreserv Biobank"},{"issue":"8","key":"1189_CR20","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1373\/clinchem.2018.287045","volume":"64","author":"JA Kirwan","year":"2018","unstructured":"Kirwan JA, Brennan L, Broadhurst D, Fiehn O, Cascante M, Dunn WB, et al. Preanalytical Processing and Biobanking Procedures of Biological Samples for Metabolomics Research: A White Paper, Community Perspective (for \u201cPrecision Medicine and Pharmacometabolomics Task Group\u201d-The Metabolomics Society Initiative). Clin Chem. 2018;64(8):1158\u201382.","journal-title":"Clin Chem"},{"issue":"7","key":"1189_CR21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1373\/clinchem.2018.298620","volume":"65","author":"JA Kirwan","year":"2019","unstructured":"Kirwan JA, Kaddurah-Daouk R, Mitchell T, Pischon T, Schmidt MA, Velagapudi V. Biobanking for Metabolomics and Lipidomics in Precision Medicine. Clin Chem. 2019;65(7):827\u201332.","journal-title":"Clin Chem"},{"issue":"4","key":"1189_CR22","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.1111\/j.1582-4934.2008.00182.x","volume":"12","author":"MJ Kirk","year":"2008","unstructured":"Kirk MJ, Hayward RM, Sproull M, Scott T, Smith S, Cooley-Zgela T, et al. Non-patient related variables affecting levels of vascular endothelial growth factor in urine biospecimens. J Cell Mol Med. 2008;12(4):1250\u20135.","journal-title":"J Cell Mol Med"},{"issue":"4","key":"1189_CR23","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1373\/clinchem.2006.080101","volume":"53","author":"JF Timms","year":"2007","unstructured":"Timms JF, Arslan-Low E, Gentry-Maharaj A, Luo Z, T\u2019Jampens D, Podust VN, et al. Preanalytic influence of sample handling on SELDI-TOF serum protein profiles. Clin Chem. 2007;53(4):645\u201356.","journal-title":"Clin Chem"},{"key":"1189_CR24","unstructured":"Webster MJ. Tissue preparation and banking. In: Hemby SE, Bahn S, editors. Progress in Brain Research [Internet]. Elsevier; 2006 [cited 2025 Feb 17]. p. 3\u201314. (Functional Genomics and Proteomics in the Clinical Neurosciences; vol. 158). Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S007961230658001X"},{"issue":"9","key":"1189_CR25","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1373\/clinchem.2005.051417","volume":"51","author":"RE Banks","year":"2005","unstructured":"Banks RE, Stanley AJ, Cairns DA, Barrett JH, Clarke P, Thompson D, et al. Influences of Blood Sample Processing on Low\u2013Molecular-Weight Proteome Identified by Surface-Enhanced Laser Desorption\/Ionization Mass Spectrometry. Clin Chem. 2005;51(9):1637\u201349.","journal-title":"Clin Chem"},{"issue":"12","key":"1189_CR26","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1373\/clinchem.2004.040303","volume":"50","author":"SK Drake","year":"2004","unstructured":"Drake SK, Bowen RAR, Remaley AT, Hortin GL. Potential Interferences from Blood Collection Tubes in Mass Spectrometric Analyses of Serum Polypeptides. Clin Chem. 2004;50(12):2398\u2013401.","journal-title":"Clin Chem"},{"issue":"2","key":"1189_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1365-2141.2004.05017.x","volume":"126","author":"S Breit","year":"2004","unstructured":"Breit S, Nees M, Schaefer U, Pfoersich M, Hagemeier C, Muckenthaler M, et al. Impact of pre-analytical handling on bone marrow mRNA gene expression. Br J Haematol. 2004;126(2):231\u201343.","journal-title":"Br J Haematol"},{"issue":"6","key":"1189_CR28","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/S0002-9440(10)64472-0","volume":"161","author":"M Srinivasan","year":"2002","unstructured":"Srinivasan M, Sedmak D, Jewell S. Effect of fixatives and tissue processing on the content and integrity of nucleic acids. Am J Pathol. 2002;161(6):1961\u201371.","journal-title":"Am J Pathol"},{"issue":"2","key":"1189_CR29","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1089\/bio.2021.0078","volume":"20","author":"L Wotton","year":"2022","unstructured":"Wotton L, Gali B, Carvalho K, Tarling T, Matzke L, Watson PH. Analysis of Trends in Biospecimen Complexity in Cancer Research Over Two Decades. Biopreserv Biobank. 2022;20(2):195\u2013200.","journal-title":"Biopreserv Biobank"},{"issue":"1","key":"1189_CR30","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1186\/s13023-018-0942-z","volume":"13","author":"M Garcia","year":"2018","unstructured":"Garcia M, Downs J, Russell A, Wang W. Impact of biobanks on research outcomes in rare diseases: a systematic review. Orphanet J Rare Dis. 2018;13(1):202.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"1189_CR31","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/cncy.20147","volume":"119","author":"HM Moore","year":"2011","unstructured":"Moore HM, Kelly AB, Jewell SD, McShane LM, Clark DP, Greenspan R, et al. Biospecimen reporting for improved study quality (BRISQ). Cancer Cytopathol. 2011;119(2):92\u2013101.","journal-title":"Cancer Cytopathol"},{"issue":"4","key":"1189_CR32","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1158\/1055-9965.EPI-09-1268","volume":"19","author":"F Betsou","year":"2010","unstructured":"Betsou F, Lehmann S, Ashton G, Barnes M, Benson EE, Coppola D, et al. Standard preanalytical coding for biospecimens: defining the sample PREanalytical code. Cancer Epidemiol Biomarkers Prev. 2010;19(4):1004\u201311.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"4","key":"1189_CR33","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1089\/bio.2012.0003","volume":"10","author":"L Norlin","year":"2012","unstructured":"Norlin L, Fransson MN, Eriksson M, Merino-Martinez R, Anderberg M, Kurtovic S, et al. A Minimum Data Set for Sharing Biobank Samples, Information, and Data: MIABIS. Biopreserv Biobank. 2012;10(4):343\u20138.","journal-title":"Biopreserv Biobank"},{"issue":"2","key":"1189_CR34","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00428-021-03151-0","volume":"479","author":"L Annaratone","year":"2021","unstructured":"Annaratone L, De Palma G, Bonizzi G, Sapino A, Botti G, Berrino E, et al. Basic principles of biobanking: from biological samples to precision medicine for patients. Virchows Arch. 2021;479(2):233\u201346.","journal-title":"Virchows Arch"},{"issue":"5","key":"1189_CR35","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1089\/bio.2023.0112","volume":"22","author":"Rush A, NSW Biobank Study Group, Catchpoole DR, Watson PH, Byrne JA","year":"2024","unstructured":"Rush A, NSW Biobank Study Group, Catchpoole DR, Watson PH, Byrne JA. An Approach to Evaluate the Costs and Outputs of Academic Biobanks. Biopreserv Biobank. 2024;22(5):463\u201374.","journal-title":"Biopreserv Biobank"},{"issue":"10","key":"1189_CR36","doi-asserted-by":"publisher","first-page":"e1001885","DOI":"10.1371\/journal.pmed.1001885","volume":"12","author":"EI Benchimol","year":"2015","unstructured":"Benchimol EI, Smeeth L, Guttmann A, Harron K, Moher D, Petersen I, et al. The REporting of studies Conducted using Observational Routinely-collected health Data (RECORD) statement. PLoS Med. 2015;12(10):e1001885.","journal-title":"PLoS Med"},{"issue":"4","key":"1189_CR37","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.socscimed.2008.11.020","volume":"68","author":"DM Secko","year":"2009","unstructured":"Secko DM, Preto N, Niemeyer S, Burgess MM. Informed consent in biobank research: a deliberative approach to the debate. Soc Sci Med. 2009;68(4):781\u20139.","journal-title":"Soc Sci Med"},{"issue":"11","key":"1189_CR38","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1016\/j.socscimed.2007.08.002","volume":"65","author":"M Boulton","year":"2007","unstructured":"Boulton M, Parker M. Informed consent in a changing environment. Soc Sci Med. 2007;65(11):2187\u201398.","journal-title":"Soc Sci Med"},{"issue":"4","key":"1189_CR39","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1017\/S1745855206004029","volume":"1","author":"O Andreas Brekke","year":"2006","unstructured":"Andreas Brekke O, Sirnes T. Population Biobanks: The Ethical Gravity of Informed Consent. BioSocieties. 2006;1(4):385\u201398.","journal-title":"BioSocieties"},{"issue":"3","key":"1189_CR40","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/S1470-2045(06)70618-0","volume":"7","author":"MG Hansson","year":"2006","unstructured":"Hansson MG, Dillner J, Bartram CR, Carlson JA, Helgesson G. Should donors be allowed to give broad consent to future biobank research? Lancet Oncol. 2006;7(3):266\u20139.","journal-title":"Lancet Oncol"},{"key":"1189_CR41","doi-asserted-by":"crossref","unstructured":"Hartanti W, Wahdi AE, Prasetiawati T, Izhati QA, Fachiroh J. Developing informed consent for academic hospital-based biobank modeling: an experience from Indonesia. Biopreserv Biobank. 2024.","DOI":"10.1089\/bio.2024.0001"},{"issue":"7542","key":"1189_CR42","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1136\/bmj.332.7542.665","volume":"332","author":"JWW Coebergh","year":"2006","unstructured":"Coebergh JWW, van Veen EB, Vandenbroucke JP, van Diest P, Oosterhuis W. One-time general consent for research on biological samples: opt out system for patients is optimal and endorsed in many countries. BMJ. 2006;332(7542):665.","journal-title":"BMJ"},{"key":"1189_CR43","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.pedn.2023.05.010","volume":"74","author":"H Phillips","year":"2024","unstructured":"Phillips H, Deshpandey M, Staveski S. Consenting in the time of the COVID-19 pandemic. J Pediatr Nurs. 2024;74:129\u201331.","journal-title":"J Pediatr Nurs"},{"issue":"18","key":"1189_CR44","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.csbj.2020.03.027","volume":"2","author":"FK Dankar","year":"2020","unstructured":"Dankar FK, Gergely M, Malin B, Badji R, Dankar SK, Shuaib K. Dynamic-informed consent: A potential solution for ethical dilemmas in population sequencing initiatives. Comput Struct Biotechnol J. 2020;2(18):913\u201321.","journal-title":"Comput Struct Biotechnol J"},{"issue":"6","key":"1189_CR45","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/ng.831","volume":"43","author":"Cambon-Thomsen A, Thorisson GA, Mabile L, BRIF Workshop Group","year":"2011","unstructured":"Cambon-Thomsen A, Thorisson GA, Mabile L, BRIF Workshop Group. The role of a bioresource research impact factor as an incentive to share human bioresources. Nat Genet. 2011;43(6):503\u20134.","journal-title":"Nat Genet"},{"issue":"4","key":"1189_CR46","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1089\/bio.2015.0105","volume":"14","author":"F Napolitani","year":"2016","unstructured":"Napolitani F, Calzolari A, Cambon-Thomsen A, Mabile L, Rossi AM, De Castro P, et al. Biobankers: Treat the Poison of Invisibility with CoBRA, a Systematic Way of Citing Bioresources in Journal Articles. Biopreserv Biobank. 2016;14(4):350\u20132.","journal-title":"Biopreserv Biobank"},{"issue":"2","key":"1189_CR47","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s12687-017-0332-6","volume":"9","author":"HC Howard","year":"2018","unstructured":"Howard HC, Mascalzoni D, Mabile L, Houeland G, Rial-Sebbag E, Cambon-Thomsen A. How to responsibly acknowledge research work in the era of big data and biobanks: ethical aspects of the Bioresource Research Impact Factor (BRIF). J Community Genet. 2018;9(2):169\u201376.","journal-title":"J Community Genet"},{"issue":"3","key":"1189_CR48","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1093\/jamiaopen\/ooaa030","volume":"3","author":"YR Rubinstein","year":"2020","unstructured":"Rubinstein YR, Robinson PN, Gahl WA, Avillach P, Baynam G, Cederroth H, et al. The case for open science: rare diseases. JAMIA Open. 2020;3(3):472\u201386.","journal-title":"JAMIA Open"},{"issue":"6","key":"1189_CR49","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1089\/bio.2023.0110","volume":"22","author":"A Rush","year":"2024","unstructured":"Rush A, Byrne JA, Watson PH. Applying Findable, Accessible, Interoperable, and Reusable Principles to Biospecimens and Biobanks. Biopreserv Biobank. 2024;22(6):550\u20136.","journal-title":"Biopreserv Biobank"},{"key":"1189_CR50","doi-asserted-by":"publisher","unstructured":"Shi J, Guo Y, He N, Xia W, Liu H, Li H. Data Governance and Distribution of Biobank: A Case from a Chinese Cancer Hospital. Biopreservation and Biobanking. 2024. https:\/\/doi.org\/10.1089\/bio.2024.0081","DOI":"10.1089\/bio.2024.0081"},{"issue":"2","key":"1189_CR51","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1089\/bio.2017.0110","volume":"16","author":"P Holub","year":"2018","unstructured":"Holub P, Kohlmayer F, Prasser F, Mayrhofer MT, Schl\u00fcnder I, Martin GM, et al. Enhancing Reuse of Data and Biological Material in Medical Research: From FAIR to FAIR-Health. Biopreserv Biobank. 2018;16(2):97\u2013105.","journal-title":"Biopreserv Biobank"},{"issue":"7","key":"1189_CR52","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/s41431-018-0160-0","volume":"26","author":"M Boeckhout","year":"2018","unstructured":"Boeckhout M, Zielhuis GA, Bredenoord AL. The FAIR guiding principles for data stewardship: fair enough? Eur J Hum Genet. 2018;26(7):931\u20136.","journal-title":"Eur J Hum Genet"},{"issue":"4","key":"1189_CR53","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/amiajnl-2014-002747","volume":"21","author":"RL Fleurence","year":"2014","unstructured":"Fleurence RL, Curtis LH, Califf RM, Platt R, Selby JV, Brown JS. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc. 2014;21(4):578\u201382.","journal-title":"J Am Med Inform Assoc"},{"issue":"12 Suppl 2","key":"1189_CR54","doi-asserted-by":"publisher","first-page":"S153","DOI":"10.1097\/MLR.0000000000001929","volume":"61","author":"LR Waitman","year":"2023","unstructured":"Waitman LR, Bailey LC, Becich MJ, Chung-Bridges K, Dusetzina SB, Espino JU, et al. Avenues for Strengthening PCORnet\u2019s Capacity to Advance Patient-Centered Economic Outcomes in Patient-Centered Outcomes Research (PCOR). Med Care. 2023;61(12 Suppl 2):S153\u201360.","journal-title":"Med Care"},{"key":"1189_CR55","unstructured":"GO FAIR [Internet]. [cited 2025 Feb 17]. Rare Diseases. Available from: https:\/\/www.go-fair.org\/implementation-networks\/overview\/rare-diseases\/"},{"issue":"5","key":"1189_CR56","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1089\/bio.2020.0144","volume":"19","author":"R Reihs","year":"2021","unstructured":"Reihs R, Proynova R, Maqsood S, Ataian M, Lablans M, Quinlan PR, et al. BBMRI-ERIC Negotiator: Implementing Efficient Access to Biobanks. Biopreserv Biobank. 2021;19(5):414\u201321.","journal-title":"Biopreserv Biobank"},{"issue":"3","key":"1189_CR57","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1089\/bio.2021.0172","volume":"21","author":"G Samuel","year":"2023","unstructured":"Samuel G, Lucassen A. Access to Biobanks: Responsibilities Within a Research Ecosystem. Biopreserv Biobank. 2023;21(3):275\u201381.","journal-title":"Biopreserv Biobank"},{"issue":"3","key":"1189_CR58","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1089\/bio.2022.0046","volume":"21","author":"BK Yadav","year":"2023","unstructured":"Yadav BK, Ng W, Vu H, Fachiroh J, Tsuruyama T, Zhou L, et al. Improving Public Trust in Biobanking: Roundtable Discussions from the 2021 ISBER Annual Meeting. Biopreserv Biobank. 2023;21(3):308\u201312.","journal-title":"Biopreserv Biobank"},{"key":"1189_CR59","unstructured":"OECD Guidelines on Human Biobanks and Genetic Research Databases [Internet]. 2009. Available from: http:\/\/www.rettdatabasenetwork.org\/Guidelines%20databases.pdf"},{"key":"1189_CR60","first-page":"1","volume":"2019","author":"M Abdaljaleel","year":"1897","unstructured":"Abdaljaleel M, Singer EJ, Yong WH. Sustainability in biobanking. Methods Mol Biol. 1897;2019:1\u20136.","journal-title":"Methods Mol Biol"},{"issue":"3","key":"1189_CR61","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1089\/bio.2023.29123.editorial","volume":"21","author":"MJ Bledsoe","year":"2023","unstructured":"Bledsoe MJ, Watson PH, Grizzle WE. Metrics for the Evaluation of Bioresources: Tell Us the Whole Story. Biopreserv Biobank. 2023;21(3):223\u20134.","journal-title":"Biopreserv Biobank"},{"issue":"7","key":"1189_CR62","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1136\/ard.2010.142489","volume":"70","author":"C Beyer","year":"2011","unstructured":"Beyer C, Distler JHW, Allanore Y, Aringer M, Avouac J, Czirj\u00e1k L, et al. EUSTAR biobanking: recommendations for the collection, storage and distribution of biospecimens in scleroderma research. Ann Rheum Dis. 2011;70(7):1178\u201382.","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"1189_CR63","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1177\/0961203311421501","volume":"20","author":"DA Isenberg","year":"2011","unstructured":"Isenberg DA, Ramsey-Goldman R, Gladman D, Hanly JG. The Systemic Lupus International Collaborating Clinics (SLICC) group - it was 20 years ago today. Lupus. 2011;20(13):1426\u201332.","journal-title":"Lupus"},{"issue":"Suppl 2","key":"1189_CR64","first-page":"S194","volume":"15","author":"R Naveen","year":"2020","unstructured":"Naveen R, Anuja AK, Rai MK, Agarwal V, Gupta L. Development of the Myocite Biobank: Cost-Efficient Model of Public Sector Investigator-Driven Biobank for Idiopathic Inflammatory Myositis. Indian J Rheumatol. 2020;15(Suppl 2):S194.","journal-title":"Indian J Rheumatol"},{"issue":"5","key":"1189_CR65","doi-asserted-by":"publisher","first-page":"e242","DOI":"10.1002\/imt2.242","volume":"3","author":"HJ Huang","year":"2024","unstructured":"Huang HJ, Liu C, Sun XW, Wei RQ, Liu LW, Chen HY, et al. The rheumatoid arthritis gut microbial biobank reveals core microbial species that associate and effect on host inflammation and autoimmune responses. iMeta. 2024;3(5):e242.","journal-title":"iMeta"},{"issue":"4","key":"1189_CR66","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s00296-012-2610-2","volume":"33","author":"M de la Vega","year":"2013","unstructured":"de la Vega M, da Silveira de Carvalho HM, Ventura R\u00edos L, Goycochea Robles MV, Casado GC. The importance of rheumatology biologic registries in Latin America. Rheumatol Int. 2013;33(4):827\u201335.","journal-title":"Rheumatol Int"},{"issue":"15","key":"1189_CR67","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12969-017-0160-6","volume":"17","author":"T Beukelman","year":"2017","unstructured":"Beukelman T, Kimura Y, Ilowite NT, Mieszkalski K, Natter MD, Burrell G, et al. The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months. Pediatr Rheumatol Online J. 2017;17(15):30.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"1","key":"1189_CR68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1038\/ejhg.2012.99","volume":"21","author":"K Hens","year":"2013","unstructured":"Hens K, Van El CE, Borry P, Cambon-Thomsen A, Cornel MC, Forzano F, et al. Developing a policy for paediatric biobanks: principles for good practice. Eur J Hum Genet. 2013;21(1):2\u20137.","journal-title":"Eur J Hum Genet"},{"issue":"10","key":"1189_CR69","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00431-008-0915-7","volume":"168","author":"W Pinxten","year":"2009","unstructured":"Pinxten W, Dierickx K, Nys H. Ethical principles and legal requirements for pediatric research in the EU: an analysis of the European normative and legal framework surrounding pediatric clinical trials. Eur J Pediatr. 2009;168(10):1225\u201334.","journal-title":"Eur J Pediatr"},{"issue":"9","key":"1189_CR70","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1038\/ejhg.2014.267","volume":"23","author":"NA Giesbertz","year":"2015","unstructured":"Giesbertz NA, Bredenoord AL, van Delden JJ. Consent procedures in pediatric biobanks. Eur J Hum Genet. 2015;23(9):1129\u201334.","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"1189_CR71","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/BOR.0000000000000119","volume":"26","author":"LG Rider","year":"2014","unstructured":"Rider LG, Dank\u00f3 K, Miller FW. Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research. Curr Opin Rheumatol. 2014;26(6):724\u201341.","journal-title":"Curr Opin Rheumatol"},{"issue":"6","key":"1189_CR72","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1136\/annrheumdis-2011-200182","volume":"71","author":"H Chinoy","year":"2012","unstructured":"Chinoy H, Adimulam S, Marriage F, New P, Vincze M, Zilahi E, et al. Interaction of HLA-DRB1*03 and smoking for the development of anti-Jo-1 antibodies in adult idiopathic inflammatory myopathies: a European-wide case study. Ann Rheum Dis. 2012;71(6):961\u20135.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"1189_CR73","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1097\/01.bor.0000434667.55020.e1","volume":"25","author":"I Lundberg","year":"2013","unstructured":"Lundberg I, Svensson J. Registries in idiopathic inflammatory myopathies. Curr Opin Rheumatol. 2013;25(6):729\u201334.","journal-title":"Curr Opin Rheumatol"},{"issue":"4","key":"1189_CR74","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1097\/MD.0b013e318260977c","volume":"91","author":"A Labirua-Iturburu","year":"2012","unstructured":"Labirua-Iturburu A, Selva-O\u2019Callaghan A, Vincze M, Dank\u00f3 K, Vencovsky J, Fisher B, et al. Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Medicine (Baltimore). 2012;91(4):206\u201311.","journal-title":"Medicine (Baltimore)"},{"issue":"12","key":"1189_CR75","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1002\/art.38137","volume":"65","author":"FW Miller","year":"2013","unstructured":"Miller FW, Cooper RG, Vencovsk\u00fd J, Rider LG, Danko K, Wedderburn LR, et al. Genome-wide association study of dermatomyositis reveals genetic overlap with other autoimmune disorders. Arthritis Rheum. 2013;65(12):3239\u201347.","journal-title":"Arthritis Rheum"},{"issue":"11","key":"1189_CR76","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.nmd.2017.07.001","volume":"27","author":"M Reza","year":"2017","unstructured":"Reza M, Cox D, Phillips L, Johnson D, Manoharan V, Grieves M, et al. MRC Centre Neuromuscular Biobank (Newcastle and London): Supporting and facilitating rare and neuromuscular disease research worldwide. Neuromuscul Disord. 2017;27(11):1054\u201364.","journal-title":"Neuromuscul Disord"},{"issue":"4","key":"1189_CR77","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1002\/acr.20695","volume":"64","author":"AM Huber","year":"2012","unstructured":"Huber AM, Robinson AB, Reed AM, Abramson L, Bout-Tabaku S, Carrasco R, et al. Consensus treatments for moderate juvenile dermatomyositis: beyond the first two months. Results of the second Childhood Arthritis and Rheumatology Research Alliance consensus conference. Arthritis Care Res (Hoboken). 2012;64(4):546\u201353.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"1","key":"1189_CR78","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1097\/MD.0b013e31827f264d","volume":"92","author":"M Shah","year":"2013","unstructured":"Shah M, Mamyrova G, Targoff IN, Huber AM, Malley JD, Rice MM, et al. The clinical phenotypes of the juvenile idiopathic inflammatory myopathies. Medicine (Baltimore). 2013;92(1):25\u201341.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"1189_CR79","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/rheumatology\/kev311","volume":"55","author":"JG Hanly","year":"2016","unstructured":"Hanly JG, O\u2019Keeffe AG, Su L, Urowitz MB, Romero-Diaz J, Gordon C, et al. The frequency and outcome of lupus nephritis: results from an international inception cohort study. Rheumatology (Oxford). 2016;55(2):252\u201362.","journal-title":"Rheumatology (Oxford)"},{"key":"1189_CR80","doi-asserted-by":"crossref","unstructured":"O\u2019Neill S, Morand EF, Hoi A. The Australian Lupus Registry and Biobank: a timely initiative. Med J Aust [Internet]. 2017 Mar 20 [cited 2025 Feb 17];206(5). Available from: https:\/\/www.mja.com.au\/journal\/2017\/206\/5\/australian-lupus-registry-and-biobank-timely-initiative","DOI":"10.5694\/mja16.01282"},{"key":"1189_CR81","unstructured":"lupus-registry [Internet]. [cited 2025 Apr 21]. Australian Lupus Registry. Available from: https:\/\/www.lupusregistry.com"},{"issue":"6","key":"1189_CR82","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/rheumatology\/key398","volume":"58","author":"L Arnaud","year":"2019","unstructured":"Arnaud L, Gavand PE, Voll R, Schwarting A, Maurier F, Blaison G, et al. Predictors of fatigue and severe fatigue in a large international cohort of patients with systemic lupus erythematosus and a systematic review of the literature. Rheumatology (Oxford). 2019;58(6):987\u201396.","journal-title":"Rheumatology (Oxford)"},{"key":"1189_CR83","unstructured":"Interreg [Internet]. [cited 2025 Apr 21]. LBBR: Lupus BioBank des OberRheins. Available from: https:\/\/www.interreg-oberrhein.eu\/projet\/lbbr-lupus-biobank-des-oberrheins\/"},{"key":"1189_CR84","unstructured":"EUSTAR \u2013 European Scleroderma Trials and Research Group [Internet]. [cited 2025 Apr 21]. Available from: https:\/\/eustar.org\/"},{"issue":"1","key":"1189_CR85","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10067-019-04792-y","volume":"39","author":"VK Shanmugam","year":"2020","unstructured":"Shanmugam VK, Frech TM, Steen VD, Hummers LK, Shah AA, Bernstein EJ, et al. Collaborative National Quality and Efficacy Registry (CONQUER) for Scleroderma: outcomes from a multicenter US-based systemic sclerosis registry. Clin Rheumatol. 2020;39(1):93\u2013102.","journal-title":"Clin Rheumatol"},{"key":"1189_CR86","unstructured":"CONQUER Registry [Internet]. Scleroderma Research Foundation. [cited 2025 Apr 21]. Available from: https:\/\/srfcure.org\/research\/conquer\/"},{"issue":"9","key":"1189_CR87","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/art.40171","volume":"69","author":"M Wu","year":"2017","unstructured":"Wu M, Baron M, Pedroza C, Salazar GA, Ying J, Charles J, et al. CCL2 in the Circulation Predicts Long-Term Progression of Interstitial Lung Disease in Patients With Early Systemic Sclerosis: Data From Two Independent Cohorts. Arthritis Rheumatol. 2017;69(9):1871\u20138.","journal-title":"Arthritis Rheumatol"},{"key":"1189_CR88","unstructured":"CSRG Website [Internet]. [cited 2025 Apr 21]. CSRG Website. Available from: https:\/\/www.canadiansclerodermaresearchgroup.org"},{"issue":"3","key":"1189_CR89","first-page":"keae317","volume":"64","author":"AS Galindo-Feria","year":"2024","unstructured":"Galindo-Feria AS, Lodin K, Horuluoglu B, Sarrafzadeh-Zargar S, Wigren E, Gr\u00e4slund S, et al. Anti-FHL1 autoantibodies in adult patients with myositis: a longitudinal follow-up analysis. Rheumatology. 2024;64(3):keae317.","journal-title":"Rheumatology"},{"issue":"6","key":"1189_CR90","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/01.md.0000189818.63141.8c","volume":"84","author":"TP O\u2019Hanlon","year":"2005","unstructured":"O\u2019Hanlon TP, Carrick DM, Arnett FC, Reveille JD, Carrington M, Gao X, et al. Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians. Medicine (Baltimore). 2005;84(6):338\u201349.","journal-title":"Medicine (Baltimore)"},{"key":"1189_CR91","unstructured":"Inicio | panlar.org [Internet]. [cited 2025 Apr 21]. Available from: https:\/\/panlar.org\/en"},{"issue":"1","key":"1189_CR92","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1093\/rheumatology\/keq261","volume":"50","author":"N Martin","year":"2011","unstructured":"Martin N, Krol P, Smith S, Murray K, Pilkington CA, Davidson JE, et al. A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years\u2019 experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies. Rheumatology (Oxford). 2011;50(1):137\u201345.","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"1189_CR93","doi-asserted-by":"publisher","first-page":"e003560","DOI":"10.1136\/rmdopen-2023-003560","volume":"9","author":"XY Fang","year":"2023","unstructured":"Fang XY, Zhang J, Qian TT, Gao P, Wu Q, Fang Q, et al. Metabolomic profiles, polygenic risk scores and risk of rheumatoid arthritis: a population-based cohort study in the UK Biobank. RMD Open. 2023;9(4):e003560.","journal-title":"RMD Open"},{"issue":"7","key":"1189_CR94","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1093\/rheumatology\/keaa773","volume":"60","author":"G Sandoval-Plata","year":"2021","unstructured":"Sandoval-Plata G, Nakafero G, Chakravorty M, Morgan K, Abhishek A. Association between serum urate, gout and comorbidities: a case\u2013control study using data from the UK Biobank. Rheumatology. 2021;60(7):3243\u201351.","journal-title":"Rheumatology"},{"key":"1189_CR95","unstructured":"UK Biobank - UK Biobank [Internet]. 2025 [cited 2025 Apr 21]. Available from: https:\/\/www.ukbiobank.ac.uk"},{"key":"1189_CR96","unstructured":"RBGB \u2013 Regionernes Bio- og Genombank [Internet]. [cited 2025 Apr 21]. Available from: https:\/\/www.rbgb.dk\/"},{"issue":"4","key":"1189_CR97","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.rdc.2021.07.010","volume":"47","author":"RC Fuhlbrigge","year":"2021","unstructured":"Fuhlbrigge RC, Schanberg LE, Kimura Y. CARRA. Rheumatic Disease Clinics of North America. 2021;47(4):531\u201343.","journal-title":"Rheumatic Disease Clinics of North America"},{"key":"1189_CR98","unstructured":"Sheridan J. CARRA. 2022 [cited 2025 Feb 16]. CARRA Registry & Biorepository. Available from: https:\/\/carragroup.org\/research\/carra-registry\/"},{"key":"1189_CR99","doi-asserted-by":"publisher","first-page":"e1613","DOI":"10.7717\/peerj.1613","volume":"4","author":"M Capocasa","year":"2016","unstructured":"Capocasa M, Anagnostou P, D\u2019Abramo F, Matteucci G, Dominici V, Destro Bisol G, et al. Samples and data accessibility in research biobanks: an explorative survey. PeerJ. 2016;4:e1613.","journal-title":"PeerJ"},{"issue":"4","key":"1189_CR100","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1200\/JCO.2009.25.6065","volume":"28","author":"DF Ransohoff","year":"2010","unstructured":"Ransohoff DF, Gourlay ML. Sources of bias in specimens for research about molecular markers for cancer. J Clin Oncol. 2010;28(4):698\u2013704.","journal-title":"J Clin Oncol"},{"issue":"9","key":"1189_CR101","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/gt.2017.29","volume":"24","author":"D Julkowska","year":"2017","unstructured":"Julkowska D, Austin CP, Cutillo CM, Gancberg D, Hager C, Halftermeyer J, et al. The importance of international collaboration for rare diseases research: a European perspective. Gene Ther. 2017;24(9):562\u201371.","journal-title":"Gene Ther"},{"issue":"3","key":"1189_CR102","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1136\/annrheumdis-2017-211904","volume":"77","author":"JB Kuemmerle-Deschner","year":"2018","unstructured":"Kuemmerle-Deschner JB, Hansmann S, Wulffraat NM, Vastert SJ, Hens K, Anton J, et al. Recommendations for collaborative paediatric research including biobanking in Europe: a Single Hub and Access point for paediatric Rheumatology in Europe (SHARE) initiative. Ann Rheum Dis. 2018;77(3):319\u201327.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1189_CR103","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s13023-022-02529-w","volume":"17","author":"N Denton","year":"2022","unstructured":"Denton N, Mulberg AE, Molloy M, Charleston S, Fajgenbaum DC, Marsh ED, et al. Sharing is caring: a call for a new era of rare disease research and development. Orphanet J Rare Dis. 2022;17(1):389.","journal-title":"Orphanet J Rare Dis"},{"issue":"2","key":"1189_CR104","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1001\/jama.2014.15939","volume":"313","author":"H Moses","year":"2015","unstructured":"Moses H, Matheson DHM, Cairns-Smith S, George BP, Palisch C, Dorsey ER. The anatomy of medical research: US and international comparisons. JAMA. 2015;313(2):174\u201389.","journal-title":"JAMA"},{"issue":"6","key":"1189_CR105","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1089\/bio.2023.0118","volume":"22","author":"HS Zelisse","year":"2024","unstructured":"Zelisse HS, de Ridder S, van Gent MDJM, Mom CH, Wisman GBA, Roes EM, et al. The Information Technology (IT) Infrastructure of the Multicenter Archipelago of Ovarian Cancer Research Biobank: A Potential Blueprint for Other Biobanks. Biopreserv Biobank. 2024;22(6):568\u201377.","journal-title":"Biopreserv Biobank"},{"key":"1189_CR106","doi-asserted-by":"publisher","first-page":"107379","DOI":"10.1016\/j.cmpb.2023.107379","volume":"231","author":"MI Ortiz-Lizcano","year":"2023","unstructured":"Ortiz-Lizcano MI, Arias-Antunez E, Hern\u00e1ndez Bravo \u00c1, Caminero MB, Rojo Guillen T, Nam Cha SH. Increasing the security and traceability of biological samples in biobanks by blockchain technology. Comput Methods Programs Biomed. 2023;231:107379.","journal-title":"Comput Methods Programs Biomed"},{"issue":"2","key":"1189_CR107","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/acr2.11211","volume":"3","author":"TE Brunekreef","year":"2021","unstructured":"Brunekreef TE, Otten HG, van den Bosch SC, Hoefer IE, van Laar JM, Limper M, et al. Text Mining of Electronic Health Records Can Accurately Identify and Characterize Patients With Systemic Lupus Erythematosus. ACR Open Rheumatol. 2021;3(2):65\u201371.","journal-title":"ACR Open Rheumatol"},{"issue":"6","key":"1189_CR108","doi-asserted-by":"publisher","first-page":"486","DOI":"10.7196\/SAMJ.2017.v107i6.12099","volume":"107","author":"CC Soo","year":"2017","unstructured":"Soo CC, Mukomana F, Hazelhurst S, Ramsay M. Establishing an academic biobank in a resource-challenged environment. S Afr Med J. 2017;107(6):486.","journal-title":"S Afr Med J"},{"issue":"1","key":"1189_CR109","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1038\/s41597-022-01807-3","volume":"9","author":"CT Hoyt","year":"2022","unstructured":"Hoyt CT, Balk M, Callahan TJ, Domingo-Fern\u00e1ndez D, Haendel MA, Hegde HB, et al. Unifying the identification of biomedical entities with the Bioregistry. Sci Data. 2022;9(1):714.","journal-title":"Sci Data"},{"issue":"5","key":"1189_CR110","first-page":"1579","volume":"25","author":"SD Sanford","year":"2017","unstructured":"Sanford SD, Beaumont JL, Snyder MA, Reichek J, Salsman JM. Clinical research participation among adolescent and young adults at an NCI-designated Comprehensive Cancer Center and affiliated pediatric hospital. Support Care Cancer. 2017;25(5):1579\u201386.","journal-title":"Support Care Cancer"},{"issue":"3","key":"1189_CR111","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1089\/bio.2022.0210","volume":"22","author":"M Karata\u015f","year":"2024","unstructured":"Karata\u015f M, Azbazdar ME, Camkiranlar M, Tercan-Avci S, Atabey N. Biobank Education for Future Physicians: Training Medical Students Through Student Research Association Networks. Biopreserv Biobank. 2024;22(3):217\u201324.","journal-title":"Biopreserv Biobank"},{"issue":"2","key":"1189_CR112","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1089\/bio.2022.0088","volume":"21","author":"D Seidler","year":"2023","unstructured":"Seidler D, Karl\u00edkov\u00e1 M, Topol\u010dan O, Sn\u00edtil\u00e1 M, Niedermair T, Brochhausen C. Establishing Biobanking in Medical Curricula-The Education Program \u201cPrecision Medicine International\u201d (eduBRoTHER). Biopreserv Biobank. 2023;21(2):200\u20137.","journal-title":"Biopreserv Biobank"},{"key":"1189_CR113","unstructured":"Rare Diseases Clinical Research Network - National Organization for Rare Disorders [Internet]. 2022 [cited 2025 Feb 4]. Available from: https:\/\/rarediseases.org\/organizations\/rare-diseases-clinical-research-network\/"},{"issue":"2","key":"1189_CR114","first-page":"207","volume":"42","author":"LA Saketkoo","year":"2024","unstructured":"Saketkoo LA, Paik JJ, Alexanderson H, Dimachkie MM, Ernste FC, Naddaf E, et al. Collaborative research in myositis-related disorders: MIHRA, a global shared community model. Clin Exp Rheumatol. 2024;42(2):207\u201312.","journal-title":"Clin Exp Rheumatol"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-025-01189-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11926-025-01189-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-025-01189-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T19:03:10Z","timestamp":1770750190000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11926-025-01189-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":114,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1189"],"URL":"https:\/\/doi.org\/10.1007\/s11926-025-01189-6","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"30 April 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"LG and CL co-lead the MIHRA biospecimen core. The views and opinions expressed belong to the authors and do not necessarily reflect those of the organizations with which they are affiliated.\n                      LAS\n                      : Abbvie, Argenx, aTyr Pharmaceuticals, Boehringer Ingelheim, CSL Behring, EMD Serono, Horizon Pharmaceuticals, Kadmon Pharmaceuticals, Kinevant Pharmaceuticals, Mallinckrodt Pharmaceuticals, Pfizer Inc, Priovant Pharmaceuticals, U.S. Department of Defense.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}],"article-number":"24"}}